Excision BioTherapeutics

Excision BioTherapeutics is a biotechnology company that develops gene therapies for treating viral infections. The company utilizes CRISPR/Cas9 technology to remove viral DNA from infected cells, effectively curing the infection. Excision BioTherapeutics focuses on developing therapies for HIV and herpes simplex virus (HSV) infections. The company's innovative approach aims to provide long-lasting cures for viral infections rather than just managing their symptoms. The company has conducted preclinical studies and is currently in the process of developing its CRISPR/Cas9 gene therapy for human clinical trials.